Blood tests to predict disease risk in healthy Hungarian adults

Plain-English translation of NCT07743021 on ClinicalTrials.gov ↗ · Source last updated August 2026 · Translation generated August 2026 · How we translate trials

What is this trial?

This is a long-term study that follows healthy people for 10 years, collecting blood samples and health information to help researchers understand how diseases develop before symptoms appear. By studying blood composition in detail using advanced techniques, researchers hope to create new blood tests that can spot disease risk early—when treatment is most effective.

Serious diseases like heart disease, cancer, diabetes, and lung disease cause most deaths in Hungary and greatly reduce quality of life. This research aims to find ways to detect these diseases much earlier, before people feel sick, so doctors can help them sooner and preserve their health longer.

Do you qualify?

You likely qualify if…

you are at least 40 years old (50+ if you have heart disease risk factors)
you feel healthy and have no current symptoms that a doctor can confirm
you are willing to give blood samples and answer health questionnaires at multiple visits over 10 years
you are willing to return for follow-up visits and health checks
you have 0–2 heart disease risk factors (such as high blood pressure, high cholesterol, or smoking history) for the lower-risk group, or at least 2 of these factors for the higher-risk group

You likely don't qualify if…

you are pregnant
you have a history of HIV, hepatitis B, or hepatitis C infection
you already have cardiovascular disease, including heart disease, heart failure, or severe lung disease
you have active cancer or a cancer diagnosis within the last 5 years
you received a vaccine within the last 14 days or are in another clinical drug trial

What participation looks like

If you qualify, you will visit the research center to give a blood sample and complete a health questionnaire. Depending on your risk level, you may be invited back for additional visits and health checks over the next 10 years. Your blood samples will be stored in a biobank for future research on new diagnostic techniques. The study is designed to be minimally invasive—mostly blood draws and surveys—while helping researchers develop better screening tools for disease prevention.

AI-generated summary from trial data · Aug 5, 2026 · Not medical advice

Trial locations(33 sites)

Hungary

04_DRC Balatonfüred_Drug Research Center LLC, Balatonfüred

14_TP Békéscsaba_Trial Pharma LLC Békéscsaba, Békéscsaba

31_TP Szt Magdolna_Trial Pharma Ltd. Magdalene Private Hospital, Budapest

08_Qualiclinic Budapest_Qualiclinic LLC, Budapest

22_MÁV Budapest_Railway Health Care Nonprofit Public Benefit Ltd., Budapest